Related Experiment Video
Updated: Jun 9, 2026
08:34
Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Unveiling the Link Between COVID-19 and Pulmonary Hypertension
Jad Abdul Khalek1, Mohamad Al Hajjar1, Zeina Al-Khalil1
1Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon, aubmc.org.lb.
Summary
The COVID-19 pandemic is linked to increased pulmonary hypertension due to direct viral effects and inflammation. Management involves vasodilators, anticoagulants, and monitoring for better patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Pulmonology
Background:
- The COVID-19 pandemic has revealed significant cardiovascular complications, including pulmonary hypertension.
- Pulmonary hypertension in COVID-19 is complex, involving vascular inflammation and thrombotic events.
Purpose of the Study:
- To review the relationship between COVID-19 and pulmonary hypertension.
- To explore pathophysiological insights, clinical implications, and therapeutic strategies.
Main Methods:
- Narrative review of literature.
- Searched MEDLINE, PubMed, and Google Scholar for studies from December 2019 to February 2025.
- Keywords: pulmonary hypertension, COVID-19.
Main Results:
- COVID-19 is associated with increased pulmonary hypertension incidence.
- Clinical signs include dyspnea and chest pain.
- Management includes vasodilators, anticoagulants, and experimental treatments with emphasis on long-term follow-up.
Conclusions:
- The COVID-19 and pulmonary hypertension intersection requires advanced diagnostics and therapeutics.
- Insights may shape public health strategies and clinical protocols.
- Future research should focus on personalized medicine and novel treatments.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...